Frequently, drug discovery has focused on minute compounds, but peptidic partners are progressively gaining traction. This novel methodology embraces combining short amino acid chains with alternative biological modalities to confront challenging illness mechanisms. By utilizing the unique characteristics of peptides – such as substantial precisi